• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

lncRNAs 与 RNA 结合蛋白 (RBPs) 的相互作用影响癌症化疗耐药中的 DNA 损伤反应。

Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.

机构信息

Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

出版信息

Mol Biol Rep. 2024 Feb 17;51(1):308. doi: 10.1007/s11033-024-09288-w.

DOI:10.1007/s11033-024-09288-w
PMID:38366290
Abstract

The DNA damage response (DDR) is a crucial cellular signaling pathway activated in response to DNA damage, including damage caused by chemotherapy. Chemoresistance, which refers to the resistance of cancer cells to the effects of chemotherapy, poses a significant challenge in cancer treatment. Understanding the relationship between DDR and chemoresistance is vital for devising strategies to overcome this resistance and improve treatment outcomes. Long non-coding RNAs (lncRNAs) are a class of RNA molecules that do not code for proteins but play important roles in various biological processes, including cancer development and chemoresistance. RNA-binding proteins (RBPs) are a group of proteins that bind to RNA molecules and regulate their functions. The interaction between lncRNAs and RBPs has been found to regulate gene expression at the post-transcriptional level, thereby influencing various cellular processes, including DDR signaling pathways. Multiple studies have demonstrated that lncRNAs can interact with RBPs to modulate the expression of genes involved in cancer chemoresistance by impacting DDR signaling pathways. Conversely, RBPs can regulate the expression and function of lncRNAs involved in DDR. Exploring these interactions can provide valuable insights for the development of innovative therapeutic approaches to overcome chemoresistance in cancer patients. This review article aims to summarize recent research on the interaction between lncRNAs and RBPs during cancer chemotherapy, with a specific focus on DDR pathways.

摘要

DNA 损伤反应(DDR)是一种重要的细胞信号通路,可被激活以应对 DNA 损伤,包括化疗引起的损伤。化疗耐药性是指癌细胞对化疗药物作用的抵抗,这是癌症治疗中的一个重大挑战。了解 DDR 与化疗耐药性之间的关系对于制定克服这种耐药性的策略以及改善治疗效果至关重要。长链非编码 RNA(lncRNA)是一类不编码蛋白质但在各种生物学过程中发挥重要作用的 RNA 分子,包括癌症的发生和化疗耐药性。RNA 结合蛋白(RBP)是一组与 RNA 分子结合并调节其功能的蛋白质。已经发现 lncRNA 与 RBPs 之间的相互作用可以通过影响 DDR 信号通路来调节转录后水平的基因表达,从而影响各种细胞过程。多项研究表明,lncRNA 可以通过影响 DDR 信号通路与 RBPs 相互作用来调节参与癌症化疗耐药性的基因的表达。相反,RBPs 可以调节参与 DDR 的 lncRNA 的表达和功能。探索这些相互作用可以为开发创新的治疗方法以克服癌症患者的化疗耐药性提供有价值的见解。本文旨在总结最近关于 lncRNA 和 RBPs 在癌症化疗过程中相互作用的研究进展,特别是在 DDR 通路方面。

相似文献

1
Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.lncRNAs 与 RNA 结合蛋白 (RBPs) 的相互作用影响癌症化疗耐药中的 DNA 损伤反应。
Mol Biol Rep. 2024 Feb 17;51(1):308. doi: 10.1007/s11033-024-09288-w.
2
Advances in the role of long non‑coding RNAs and RNA‑binding proteins in regulating DNA damage repair in cancer cells.长链非编码 RNA 和 RNA 结合蛋白在调节癌细胞 DNA 损伤修复中的作用的研究进展。
Int J Mol Med. 2023 Oct;52(4). doi: 10.3892/ijmm.2023.5296. Epub 2023 Aug 24.
3
Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.DNA损伤反应中的非编码RNA:癌症治疗的机遇
Methods Mol Biol. 2018;1699:3-21. doi: 10.1007/978-1-4939-7435-1_1.
4
LncRNAs and their RBPs: How to influence the fate of stem cells?长链非编码 RNA 及其结合蛋白:如何影响干细胞的命运?
Stem Cell Res Ther. 2022 May 3;13(1):175. doi: 10.1186/s13287-022-02851-x.
5
New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer.长非编码 RNA 与 RNA 结合蛋白在癌症中的相互作用的新见解。
Cancer Commun (Lond). 2022 Feb;42(2):117-140. doi: 10.1002/cac2.12254. Epub 2022 Jan 12.
6
Interactions between long non‑coding RNAs and RNA‑binding proteins in cancer (Review).长非编码 RNA 与 RNA 结合蛋白在癌症中的相互作用(综述)。
Oncol Rep. 2021 Dec;46(6). doi: 10.3892/or.2021.8207. Epub 2021 Oct 22.
7
RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer.RNA 结合蛋白作为癌症中长非编码 RNA 的重要调节剂。
Int J Mol Sci. 2020 Apr 23;21(8):2969. doi: 10.3390/ijms21082969.
8
DNA-Damage Response RNA-Binding Proteins (DDRBPs): Perspectives from a New Class of Proteins and Their RNA Targets.DNA 损伤反应 RNA 结合蛋白(DDRBPs):一类新的蛋白质及其 RNA 靶标的研究视角。
J Mol Biol. 2017 Oct 27;429(21):3139-3145. doi: 10.1016/j.jmb.2016.09.019. Epub 2016 Sep 29.
9
A review of the complex interplay between chemoresistance and lncRNAs in lung cancer.肺癌中化疗耐药与长链非编码RNA之间复杂相互作用的综述
J Transl Med. 2024 Dec 5;22(1):1109. doi: 10.1186/s12967-024-05877-2.
10
The characteristic landscape of lncRNAs classified by RBP-lncRNA interactions across 10 cancers.通过10种癌症中RBP-lncRNA相互作用分类的lncRNAs的特征图谱。
Mol Biosyst. 2017 Jun 1;13(6):1142-1151. doi: 10.1039/c7mb00144d. Epub 2017 Apr 26.

引用本文的文献

1
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
2
hnRNPH1: A Multifaceted Regulator in RNA Processing and Disease Pathogenesis.异质性核糖核蛋白H1(hnRNPH1):RNA加工和疾病发病机制中的多面调节因子
Int J Mol Sci. 2025 May 28;26(11):5159. doi: 10.3390/ijms26115159.
3
Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis.

本文引用的文献

1
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer.RNA 结合蛋白(RBPs)及其在癌症中 DNA 损伤和辐射反应中的作用。
Adv Drug Deliv Rev. 2022 Dec;191:114569. doi: 10.1016/j.addr.2022.114569. Epub 2022 Oct 14.
2
DNA Damage Regulates the Functions of the RNA Binding Protein Sam68 through ATM-Dependent Phosphorylation.DNA损伤通过ATM依赖性磷酸化调节RNA结合蛋白Sam68的功能。
Cancers (Basel). 2022 Aug 9;14(16):3847. doi: 10.3390/cancers14163847.
3
DNA damage and metabolic mechanisms of cancer drug resistance.
肝细胞癌中的巨噬细胞极化:从以长链非编码RNA为中心的视角看肿瘤进展与转移
Clin Exp Med. 2025 May 25;25(1):173. doi: 10.1007/s10238-025-01711-1.
癌症耐药性的DNA损伤与代谢机制
Cancer Drug Resist. 2022 May 5;5(2):368-379. doi: 10.20517/cdr.2021.148. eCollection 2022.
4
Chemotherapy Side-Effects: Not All DNA Damage Is Equal.化疗副作用:并非所有DNA损伤都是相同的。
Cancers (Basel). 2022 Jan 26;14(3):627. doi: 10.3390/cancers14030627.
5
LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells.外泌体来源的长链非编码 RNA SNHG12 通过激活 NF-κB 信号通路促进癌相关成纤维细胞促进顺铂耐药的非小细胞肺癌细胞的进展。
Bioengineered. 2022 Jan;13(1):1838-1857. doi: 10.1080/21655979.2021.2018099.
6
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.p53 介导的细胞对 DNA 损伤治疗药物的反应差异。
Int J Mol Sci. 2021 Oct 31;22(21):11828. doi: 10.3390/ijms222111828.
7
p53 mRNA Metabolism Links with the DNA Damage Response.p53 mRNA 代谢与 DNA 损伤反应相关联。
Genes (Basel). 2021 Sep 20;12(9):1446. doi: 10.3390/genes12091446.
8
Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1.长链非编码RNA MIR200CHG通过与YB-1相互作用并使其稳定来促进乳腺癌的增殖、侵袭和耐药性。
NPJ Breast Cancer. 2021 Jul 16;7(1):94. doi: 10.1038/s41523-021-00293-x.
9
ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.ADAMTS9-AS2:肿瘤发生中的一种功能性长非编码 RNA。
Curr Pharm Des. 2021;27(23):2722-2727. doi: 10.2174/1381612827666210325105106.
10
Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.非编码 RNA 参与糖尿病血管并发症中的 DNA 甲基化、组蛋白甲基化和乙酰化。
Pharmacol Res. 2021 Aug;170:105520. doi: 10.1016/j.phrs.2021.105520. Epub 2021 Feb 25.